Showing results (401-410 of 423) with videos related to
Sort By:
Pageof 43
Clinical and Experimental Rheumatology|February 10, 2023
Current status of clinical outcome measures in inclusion body myositis: a systematised reviewBhaskar Roy, Matteo Lucchini, James B Lilleker, et al.Muscle & Nerve|December 10, 2021
A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosisMerit E Cudkowicz, Stacy R Lindborg, Namita A Goyal, et al.Muscle & Nerve|April 9, 2024
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomesStacy R Lindborg, Namita A Goyal, Jonathan Katz, et al.ESMO Open|March 12, 2026
Progression patterns and clinical outcomes in patients with cutaneous squamous-cell carcinoma following anti-PD-1 therapy failureK Khaddour, P Kote, M Liu, et al.The New England Journal of Medicine|October 5, 2022
Trial of Intravenous Immune Globulin in DermatomyositisRohit Aggarwal, Christina Charles-Schoeman, Joachim Schessl, et al.Journal of Neuromuscular Diseases|February 6, 2026
A randomized, double-blind, placebo-controlled study of losmapimod in patients with facioscapulohumeral muscular dystrophy: Results of the REACH studyNicol C Voermans, Jeffrey M Statland, Lawrence J Hayward, et al.The Lancet. Neurology|May 23, 2024
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trialMichael Benatar, Thomas Hansen, Dror Rom, et al.The Lancet. Neurology|April 17, 2024
Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trialRabi Tawil, Kathryn R Wagner, Johanna I Hamel, et al.Muscle & Nerve|August 26, 2025
Multicenter Expanded Access Protocol for Research Through Access to Trehalose in People With Amyotrophic Lateral SclerosisBrooke Krivickas, Erica Scirocco, Elisa Giacomelli, et al.Muscle & Nerve|January 8, 2017
Assessing mNIS+7Ionis and international neurologists' proficiency in a familial amyloidotic polyneuropathy trialPeter J Dyck, John C Kincaid, P James B Dyck, et al.Pageof 43